-
1
-
-
70049094380
-
Target distribution of magnetic albumin nanoparticles containing adriamycin in model of transplanted liver cancer in rats
-
9
-
Gong L S, Zhang Y D, Liu S. Target distribution of magnetic albumin nanoparticles containing adriamycin in model of transplanted liver cancer in rats. Chin J Hepatobiliary Surg (Chinese), 2003,9(9):543-546
-
(2003)
Chin J Hepatobiliary Surg (Chinese)
, vol.9
, pp. 543-546
-
-
Gong, L.S.1
Zhang, Y.D.2
Liu, S.3
-
2
-
-
0033559933
-
Estimates of the worldwide incidence of 25 major cancers in 1990
-
Parkin D M, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer, 1999, 80:827-841
-
(1999)
Int J Cancer
, vol.80
, pp. 827-841
-
-
Parkin, D.M.1
Pisani, P.2
Ferlay, J.3
-
3
-
-
0034781817
-
Metastatic human hepatocellular carcinoma models in nude mice and cell line with metastatic potential
-
Tang Z Y, Sun F X, Tian J et al. Metastatic human hepatocellular carcinoma models in nude mice and cell line with metastatic potential. World J Gastroenterol, 2001,7:597-601
-
(2001)
World J Gastroenterol
, vol.7
, pp. 597-601
-
-
Tang, Z.Y.1
Sun, F.X.2
Tian, J.3
-
4
-
-
0028212137
-
Recurrence after resection of fetoprotein-positive hepatocellular carcinoma
-
Zhou X D, Tang Z Y, Yu Y Q et al. Recurrence after resection of fetoprotein-positive hepatocellular carcinoma. J Cancer Res Clin Oncol, 1994,120:369-373
-
(1994)
J Cancer Res Clin Oncol
, vol.120
, pp. 369-373
-
-
Zhou, X.D.1
Tang, Z.Y.2
Yu, Y.Q.3
-
5
-
-
0029841614
-
Indications for and effectiveness of a second hepatic resection for recurrent hepatocellular carcinoma
-
Shuto T, Kinoshita H, Hirohashi K et al. Indications for and effectiveness of a second hepatic resection for recurrent hepatocellular carcinoma. Hepatogastroenterology, 1996,43:932-937
-
(1996)
Hepatogastroenterology
, vol.43
, pp. 932-937
-
-
Shuto, T.1
Kinoshita, H.2
Hirohashi, K.3
-
6
-
-
0036046677
-
Molecular targets for prevention of hepatocellular carcinoma
-
Blum H E. Molecular targets for prevention of hepatocellular carcinoma. Dig Dis, 2002,20:81-90
-
(2002)
Dig Dis
, vol.20
, pp. 81-90
-
-
Blum, H.E.1
-
7
-
-
1642375906
-
The efficacy of the combination therapy of 5-fluorouracil cisplatin and leucovorin for hepatocellular carcinoma and its predictable factors
-
4
-
Kogure T, Ueno Y, Iwasaki T et al. The efficacy of the combination therapy of 5-fluorouracil cisplatin and leucovorin for hepatocellular carcinoma and its predictable factors. Cancer Chemother Pharmacol, 2004,53(4):296-304
-
(2004)
Cancer Chemother Pharmacol
, vol.53
, pp. 296-304
-
-
Kogure, T.1
Ueno, Y.2
Iwasaki, T.3
-
8
-
-
12444293395
-
Combination chemotherapy with continuous 5-fluorouracil and low-dose cisplatin infusion for advanced hepatocellular carcinoma
-
2C
-
Tainok H, Tsuiji A, Morita S et al. Combination chemotherapy with continuous 5-fluorouracil and low-dose cisplatin infusion for advanced hepatocellular carcinoma. Anticancer Res, 2003,23(2C):1891-1897
-
(2003)
Anticancer Res
, vol.23
, pp. 1891-1897
-
-
Tainok, H.1
Tsuiji, A.2
Morita, S.3
-
9
-
-
0035742390
-
Systemic chemotherapy with epirubicin for treatment of advanced or multifocal hepatocellular carcinoma
-
5
-
Pohl J, Zuna I, Stremmel W et al. Systemic chemotherapy with epirubicin for treatment of advanced or multifocal hepatocellular carcinoma. Chemotherapy, 2001,47(5):359-65
-
(2001)
Chemotherapy
, vol.47
, pp. 359-65
-
-
Pohl, J.1
Zuna, I.2
Stremmel, W.3
-
10
-
-
12444335256
-
Low-dose chemotherapy of cisplatin and 5-fluorouracil or doxorubicin via implanted fusion port for unresectable hepatocellular carcinoma
-
2C
-
Murata K, Shiraki K, Kawakita T et al. Low-dose chemotherapy of cisplatin and 5-fluorouracil or doxorubicin via implanted fusion port for unresectable hepatocellular carcinoma. Anticancer Res, 2003,23(2C):1719-1722
-
(2003)
Anticancer Res
, vol.23
, pp. 1719-1722
-
-
Murata, K.1
Shiraki, K.2
Kawakita, T.3
-
11
-
-
0036218413
-
Intrahepatic arterial infusion of chemotherapy: Clinical results
-
2
-
Dizon D S, Kemeny N E. Intrahepatic arterial infusion of chemotherapy: clinical results. Semin Oncol, 2002,29(2):126-135
-
(2002)
Semin Oncol
, vol.29
, pp. 126-135
-
-
Dizon, D.S.1
Kemeny, N.E.2
-
12
-
-
34447535945
-
Target distribution of magnetic nanoparticle containing drug in vivo and its therapeutical efficiency for liver cancer
-
6
-
Zhang Y D, Gong L S, Pan Y F et al. Target distribution of magnetic nanoparticle containing drug in vivo and its therapeutical efficiency for liver cancer. China Journal of Medical Engineering, 2003,11(6):18-21
-
(2003)
China Journal of Medical Engineering
, vol.11
, pp. 18-21
-
-
Zhang, Y.D.1
Gong, L.S.2
Pan, Y.F.3
-
13
-
-
49749116889
-
Nanotechnology and treatment and prevention of tumor
-
2
-
Lv D P, Li L J, Liu X Q. Nanotechnology and treatment and prevention of tumor. Chin J Prac Surg (Chinese), 2002,22(2):126-128
-
(2002)
Chin J Prac Surg (Chinese)
, vol.22
, pp. 126-128
-
-
Lv, D.P.1
Li, L.J.2
Liu, X.Q.3
-
14
-
-
0030035871
-
Systemic and adjuvant therapy for patients with pancreatic carcinoma
-
3Suppl
-
Clark J W, Glicksman A S, Wanebo H J. Systemic and adjuvant therapy for patients with pancreatic carcinoma. Cancer, 1996,78(3 Suppl):688-693
-
(1996)
Cancer
, vol.78
, pp. 688-693
-
-
Clark, J.W.1
Glicksman, A.S.2
Wanebo, H.J.3
-
15
-
-
33745987641
-
Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner
-
2
-
Yan X, Fraser M, Qiu Q et al. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner. Gynecol Oncol, 2006,102(2):348-355
-
(2006)
Gynecol Oncol
, vol.102
, pp. 348-355
-
-
Yan, X.1
Fraser, M.2
Qiu, Q.3
-
16
-
-
22144463566
-
The irinotecan/5-fluorouracil combination induces apoptosis and enhances manganese superoxide dismutase activity in HT-29 human colon carcinoma cells
-
2-3
-
Grivicich I, Regner A, da Rocha A B et al. The irinotecan/5-fluorouracil combination induces apoptosis and enhances manganese superoxide dismutase activity in HT-29 human colon carcinoma cells. Chemotherapy, 2005,51(2-3):93-102
-
(2005)
Chemotherapy
, vol.51
, pp. 93-102
-
-
Grivicich, I.1
Regner, A.2
Da Rocha, A.B.3
-
17
-
-
0028329172
-
Apoptosis its significance in cancer and cancer therapy
-
8
-
Kerr J F, Winterford C M, Harmon B V. Apoptosis its significance in cancer and cancer therapy. Cancer, 1994, 73(8):2013-2026
-
(1994)
Cancer
, vol.73
, pp. 2013-2026
-
-
Kerr, J.F.1
Winterford, C.M.2
Harmon, B.V.3
-
18
-
-
0028809209
-
Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death
-
2
-
Yang E, Zha J, Jockel J et al. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell, 1995,80(2):285-291
-
(1995)
Cell
, vol.80
, pp. 285-291
-
-
Yang, E.1
Zha, J.2
Jockel, J.3
-
19
-
-
0029671360
-
The ability of Bcl-x(L) and Bcl-2 to prevent apoptosis can be differentially regulated
-
1
-
Gottschalk A R, Boise L H, Oltvai Z N et al. The ability of Bcl-x(L) and Bcl-2 to prevent apoptosis can be differentially regulated. Cell Death Differ, 1996,3(1):113-118
-
(1996)
Cell Death Differ
, vol.3
, pp. 113-118
-
-
Gottschalk, A.R.1
Boise, L.H.2
Oltvai, Z.N.3
-
20
-
-
0036333713
-
C-Myc functionally cooperates with Bax to induce apoptosis
-
17
-
Juin P, Hunt A, Littlewood T et al. c-Myc functionally cooperates with Bax to induce apoptosis. Mol Cell Biol, 2002,22(17):6158-6169
-
(2002)
Mol Cell Biol
, vol.22
, pp. 6158-6169
-
-
Juin, P.1
Hunt, A.2
Littlewood, T.3
-
21
-
-
49749112990
-
Histone Arg modifications and p53 regulate the expression of OKL38, a mediator of apoptosis
-
29
-
Yao H, Li P, Venters B J et al. Histone Arg modifications and p53 regulate the expression of OKL38, a mediator of apoptosis. J Biol Chem, 2008,283(29):20060-20068
-
(2008)
J Biol Chem
, vol.283
, pp. 20060-20068
-
-
Yao, H.1
Li, P.2
Venters, B.J.3
-
22
-
-
0033083990
-
Chemotherapy augments TRAIL-induced apoptosis in breast cell lines
-
3
-
Keane M M, Ettenberg S A, Nau M M et al. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. Cancer Res, 1999,59(3):734-741
-
(1999)
Cancer Res
, vol.59
, pp. 734-741
-
-
Keane, M.M.1
Ettenberg, S.A.2
Nau, M.M.3
-
23
-
-
47049099431
-
TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and invasion in pancreatic cancer
-
4
-
Wang Z, Song W, Aboukameel A et al. TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and invasion in pancreatic cancer. Int J Cancer. 2008,123(4):958-966
-
(2008)
Int J Cancer
, vol.123
, pp. 958-966
-
-
Wang, Z.1
Song, W.2
Aboukameel, A.3
-
24
-
-
23844504107
-
Dynamic expression of apoptosis-related genes during development of laboratory hepatocellular carcinoma and its relation to apoptosis
-
30
-
Duan X X, Ou J S, Li Y et al. Dynamic expression of apoptosis-related genes during development of laboratory hepatocellular carcinoma and its relation to apoptosis. World J Gastroenterol, 2005,11(30):4740-4744
-
(2005)
World J Gastroenterol
, vol.11
, pp. 4740-4744
-
-
Duan, X.X.1
Ou, J.S.2
Li, Y.3
|